Related Experiment Video
Updated: May 22, 2026

Assessment of Stress Effects on Cognitive Flexibility using an Operant Strategy Shifting Paradigm
Published on: May 4, 2020
[Schizophrenia and carbonyl stress]
Makoto Arai1, Mitsuhiro Miyashita, Tomoe Ichikawa
1Tokyo Metropolitan Institute of Medical Science, Department of Psychiatry and Behavioral Sciences, Project for Schizophrenia & Affective Disorders Research.
Schizophrenia patients show abnormal Glyoxalase I (GLO1) enzyme function, leading to increased pentosidine and decreased Vitamin B6 levels. This discovery may reveal new therapeutic targets for schizophrenia treatment.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Glyoxalase I (GLO1) enzyme is crucial for detoxifying reactive carbonyl compounds.
- Impaired GLO1 function causes carbonyl stress and advanced glycation end product (AGE) formation, such as pentosidine.
- Schizophrenia is a complex psychiatric disorder with potential biochemical underpinnings.
Purpose of the Study:
- To investigate genetic abnormalities in Glyoxalase I (GLO1) in schizophrenia patients.
- To examine the biochemical consequences of GLO1 impairment in this population.
- To explore potential links between GLO1 function, AGEs, and Vitamin B6 levels in schizophrenia.
Main Methods:
- Analysis of genetic abnormalities in the GLO1 gene.
- Measurement of plasma pentosidine levels.
- Assessment of pyridoxal (a form of Vitamin B6) levels in schizophrenia patients.
Main Results:
- Seventeen schizophrenia patients (17.4%) exhibited elevated plasma pentosidine levels without physical complications.
- A significant decrease in pyridoxal levels was observed in schizophrenia patients.
- Evidence of genetic abnormalities in GLO1 was found in the studied schizophrenia population.
Conclusions:
- This study provides the first evidence of GLO1 genetic abnormalities and associated biochemical derangements in schizophrenia.
- Elevated pentosidine and reduced pyridoxal levels suggest a role for carbonyl stress in schizophrenia pathophysiology.
- Further metabolomic and clinical studies could lead to novel therapeutic strategies for schizophrenia.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Schizophrenia
Stress
Components of Stress
Interestingly, the hidden cube faces also experience these stresses, equal and opposite to those on the...

